Lysosome-associated protein transmembrane-4 beta (LAPTM4B) was first identified from hepatocellular carcinoma (HCC), and the LAPTM4B-35 overexpression was associated with poor prognosis of HCC [8]. Here, LAPTM4B is linked to hepatocellular carcinoma.